As the world heads toward a dementia “tsunami” from 55 million people living with it today to 78 million by 2030 and 139 million by 2050, the numbers behind Alzheimer’s and dementia are already reshaping families, health systems, and policies worldwide.
Key Takeaways
- In 2021, there were an estimated 55 million people living with dementia worldwide, and this is projected to rise to 78 million in 2030 and 139 million in 2050.
- Dementia affects 5%–8% of people aged 60 years and older worldwide.
- The World Alzheimer Report 2018 estimated that 50 million people worldwide were living with dementia in 2018.
- About 80% of dementia cases are in low- and middle-income countries.
- Smoking is associated with increased risk of dementia later in life; one estimate is that 14% of dementia cases could be attributed to smoking.
- Physical inactivity is estimated to contribute to 13% of dementia cases.
- In the US, Alzheimer’s disease is the 6th leading cause of death.
- In 2021, Alzheimer’s disease contributed to 321, 000 deaths in the US.
- In 2022, Alzheimer’s disease was listed as the 6th leading cause of death in the US.
- Global societal cost of dementia is estimated at $1 trillion (US dollars) per year (World Alzheimer Report 2015 estimate).
- The World Alzheimer Report 2015 estimated global cost of dementia in 2015 at about US$818 billion.
- The World Alzheimer Report 2018 estimated global societal cost of dementia at US$1 trillion in 2018.
- WHO estimates dementia affects about 55 million people globally (health outcomes context).
- WHO states dementia is among the leading causes of disability and dependency among older people.
- WHO emphasizes early diagnosis and treatment to improve quality of life.
Dementia affects tens of millions, rising worldwide, and is partially preventable.
Epidemiology & Prevalence
1In 2021, there were an estimated 55 million people living with dementia worldwide, and this is projected to rise to 78 million in 2030 and 139 million in 2050.[1]
Verified2Dementia affects 5%–8% of people aged 60 years and older worldwide.[1]
Verified3The World Alzheimer Report 2018 estimated that 50 million people worldwide were living with dementia in 2018.[2]
Verified4The Global Burden of Disease Study 2019 estimated 57.4 million people had dementia in 2019.[3]
Directional5In the Global Burden of Disease Study 2019, dementia increased from 45.0 million in 1990 to 57.4 million in 2019.[3]
Single source6In 2019, dementia ranked as the 7th leading cause of disability worldwide.[4]
Verified7Dementia causes 2.8% of global disability-adjusted life years (DALYs).[5]
Verified8Globally, dementia accounted for 0.9% of all deaths in 2019.[5]
Verified9The Alzheimer's Association estimated 6.5 million Americans (age 65+) were living with Alzheimer’s disease in 2022.[6]
Directional10The Alzheimer's Association estimated 11.6 million Americans were projected to have Alzheimer’s disease by 2050.[6]
Single source11The Alzheimer's Association estimated that 32% of Americans age 85+ have Alzheimer’s disease.[6]
Verified12The Alzheimer's Association estimated that among adults 65+, Alzheimer’s disease is the 5th leading cause of death.[6]
Verified13In Canada, 747,000 people were living with dementia in 2021.[7]
Verified14In Canada, prevalence is estimated to rise to 1,503,000 by 2050.[7]
Directional15In the UK, an estimated 850,000 people were living with dementia in 2016.[8]
Single source16The UK estimate projects 1 million people with dementia by 2021.[8]
Verified17In Australia, 421,000 people were estimated to be living with dementia in 2018.[9]
Verified18In Australia, prevalence is estimated to reach 1.1 million people by 2050.[9]
Verified19In the EU, an estimated 10.5 million people had dementia in 2018.[10]
Directional20In the EU, numbers of people with dementia are projected to increase to 14.1 million by 2030.[10]
Single source21In the EU, numbers of people with dementia are projected to increase to 19.0 million by 2050.[10]
Verified22The WHO notes that dementia affects around 10% of people over age 70 in high-income countries.[1]
Verified23The WHO notes that dementia affects 5%–8% of people aged 60 years and older worldwide.[1]
Verified24In the UK, around 1 in 6 people aged 80+ have dementia.[11]
Directional25In the UK, the number of people with dementia is projected to reach 1.6 million by 2040.[11]
Single source26In Japan, 5.0 million people were estimated to have dementia in 2012.[12]
Verified27Japan projects dementia prevalence to reach 7.3 million in 2025.[12]
Verified28Japan projects dementia prevalence to reach 9.0 million in 2035.[12]
Verified29Japan projects dementia prevalence to reach 14.0 million in 2060.[12]
Directional30In the US, there are about 1.6 million people with Alzheimer’s who have not been diagnosed.[6]
Single source31In the US, Alzheimer’s is expected to affect 1 in 10 people age 65+ (as estimated by the Alzheimer’s Association).[6]
Verified32People with dementia have a survival of 4–7 years after diagnosis on average (range 1–10 years).[1]
Verified33Dementia prevalence varies from 1% to 2% among people aged 65–69 to 30%–50% among people aged 85+.[1]
Verified34The WHO estimates that in 2019 dementia affected about 55 million people worldwide.[13]
Directional35Dementia is a major cause of dependency and disability among older people.[1]
Single source36In China, about 9.3 million people were estimated to have dementia in 2010.[14]
Verified37In China, about 15.4 million people were estimated to have dementia in 2015.[14]
Verified38In China, projected dementia cases are 26.4 million in 2030.[14]
Verified39In China, projected dementia cases are 37.9 million in 2050.[14]
Directional40Global annual incidence is estimated at 10 million new cases of dementia each year.[1]
Single source41In 2016, the Alzheimer's Disease International estimated 9.9 million new cases of dementia globally.[15]
Verified42In 2018, the World Alzheimer Report estimated 10 million new cases each year.[16]
Verified43By 2050, the number of people with dementia is expected to triple compared with 2019 (WHO projection to 139 million in 2050 from 55 million in 2021).[1]
VerifiedEpidemiology & Prevalence Interpretation
With dementia already claiming the attention of roughly 55 million people worldwide in 2021 and projected to swell to 78 million by 2030 and 139 million by 2050, it is hard not to see this as a steadily growing global tide of disability, affecting millions in every region, ranking among the top causes of disability, and delivering years of life with shrinking independence as new cases still emerge at nearly 10 million every year.
Risk Factors & Prevention
1About 80% of dementia cases are in low- and middle-income countries.[1]
Verified2Smoking is associated with increased risk of dementia later in life; one estimate is that 14% of dementia cases could be attributed to smoking.[17]
Verified3Physical inactivity is estimated to contribute to 13% of dementia cases.[17]
Verified4Hypertension in midlife is estimated to contribute to 19% of dementia cases.[17]
Directional5Obesity is estimated to contribute to 6% of dementia cases.[17]
Single source6Hearing loss is estimated to contribute to 8% of dementia cases.[17]
Verified7Alcohol consumption is estimated to contribute to 3% of dementia cases.[17]
Verified8Diabetes is estimated to contribute to 7% of dementia cases.[17]
Verified9Depression is estimated to contribute to 4% of dementia cases.[17]
Directional10Air pollution is estimated to contribute to 2% of dementia cases.[17]
Single source11Low educational attainment is estimated to contribute to 8% of dementia cases.[17]
Verified12One study estimated that up to 40% of dementia cases may be preventable by modifying risk factors.[1]
Verified13Dementia prevention: WHO says risk can be reduced by managing hypertension, diabetes, obesity, remaining physically active, not smoking, and limiting alcohol.[1]
Verified14WHO recommends regular physical activity to reduce dementia risk.[1]
Directional15WHO states that smoking and alcohol use increase risk of dementia.[1]
Single source16WHO identifies hearing impairment as a risk factor for cognitive decline and dementia.[1]
Verified17WHO identifies social engagement as protective against dementia.[1]
Verified18The Lancet Commission estimated that 35% of dementia is attributable to 7 risk factors: hearing loss, hypertension, diabetes, obesity, smoking, depression, and physical inactivity.[17]
Verified19The Lancet Commission estimated that 40% of dementia cases are attributable to risk factors (including air pollution, alcohol, and low education).[17]
Directional20UK NICE guideline recommends offering people with dementia a structured activity plan (as part of non-pharmacological risk management).[18]
Single source21NICE guideline NG97 recommends interventions should include activities such as maintaining independence and meaningful activities.[18]
Verified22The Alzheimer's Association reports that cardiovascular risk factors are associated with increased risk of cognitive decline and Alzheimer’s.[19]
Verified23In the World Alzheimer Report 2014, 35% of dementias are thought to be preventable by addressing risk factors.[20]
Verified24World Health Organization states that dementia risk increases with age, but can be reduced with healthy lifestyle.[13]
Directional25WHO notes that hypertension is a risk factor for dementia.[13]
Single source26WHO notes that diabetes is a risk factor for dementia.[13]
Verified27WHO notes that obesity is a risk factor for dementia.[13]
Verified28WHO notes that physical inactivity is a risk factor for dementia.[13]
Verified29WHO notes that depression may increase dementia risk.[13]
Directional30WHO notes that hearing loss is a risk factor for dementia.[13]
Single source31WHO notes that smoking is a risk factor for dementia.[13]
Verified32WHO notes that excessive alcohol consumption increases dementia risk.[13]
Verified33WHO notes that air pollution exposure increases risk of cognitive decline and dementia.[13]
Verified34WHO emphasizes that cognitive training and education across the life course may help preserve cognitive health.[13]
Directional35A meta-analysis found that cardiovascular risk reduction may reduce dementia risk; one estimate is that statin use reduces risk by about 1/3 (33%) in observational studies.[14]
Single source36The Lancet Commission risk factor estimates: about 8% hearing loss, 19% hypertension, 7% diabetes, 6% obesity, 14% smoking, 4% depression, 13% physical inactivity (sum up to 57%; commission uses overlapping attribution).[17]
Verified37In the LANCET Commission framework, the estimate for potentially modifiable risk factors across the lifespan is up to 40%.[17]
Verified38The WHO recommends addressing smoking and alcohol to reduce dementia risk.[1]
Verified39WHO recommends controlling blood pressure as a key dementia risk reduction strategy.[1]
Directional40WHO recommends preventing diabetes to reduce dementia risk.[1]
Single sourceRisk Factors & Prevention Interpretation
Dementia risk is being quietly shaped worldwide by a pile of largely preventable lifestyle and health factors, with most cases occurring in low and middle income countries, and research suggesting that up to 40% may be avoidable by tackling things like midlife hypertension, smoking, inactivity, obesity, diabetes, hearing loss, depression, and poor education, so the best “memory hack” is really public health done consistently.
Diagnosis, Disease Course & Outcomes
1In the US, Alzheimer’s disease is the 6th leading cause of death.[21]
Verified2In 2021, Alzheimer’s disease contributed to 321, 000 deaths in the US.[22]
Verified3In 2022, Alzheimer’s disease was listed as the 6th leading cause of death in the US.[21]
Verified4For people with dementia, survival after diagnosis is typically 4–7 years.[1]
Directional5The WHO notes survival after dementia diagnosis ranges from 1 to 10 years.[1]
Single source6Dementia is characterized by deterioration in memory and thinking ability that interferes with daily life.[1]
Verified7DSM-5 criteria require evidence of significant cognitive decline in one or more cognitive domains and interference with independence in daily activities.[23]
Verified8ICD-11 defines dementia as a syndrome due to brain disease, usually chronic or progressive, in which cognitive impairment affects independence in everyday activities.[24]
Verified9NICE guideline NG97 recommends medication review and assessment for reversible causes of symptoms in people with dementia.[18]
Directional10NICE NG97 recommends a structured and holistic assessment of cognitive impairment and social circumstances.[18]
Single source11NICE NG97 recommends offering chaperoned assessment and shared decision-making for people with dementia.[18]
Verified12The WHO states there is no cure for dementia currently.[1]
Verified13The WHO states that treatment can slow symptoms and improve quality of life.[1]
Verified14The WHO notes that dementia symptoms can be managed with pharmacological and non-pharmacological interventions.[1]
Directional15In the US, Medicare covers some dementia-related services, but there is no Medicare Part to cover long-term custodial care (statistic from CMS overview).[25]
Single source16Delirium can mimic or occur alongside dementia; in hospitals, delirium incidence is common among older adults (about 20%–30%).[26]
Verified17The conversion rate from mild cognitive impairment to dementia is about 10%–15% per year.[27]
Verified18NIH/NIA states that about 60% of people with mild cognitive impairment progress to Alzheimer’s disease over time.[28]
Verified19The National Institute on Aging notes that not all MCI progresses to dementia.[28]
Directional20The FDA approval for aducanumab is for early Alzheimer’s disease; (not a dementia cure; indicator).[29]
Single source21The FDA’s Leqembi (lecanemab) is approved for patients with early Alzheimer’s to reduce cognitive decline (reference).[29]
Verified22In the pivotal trial for lecanemab, the mean change from baseline in CDR-SB was 1.21 points in the lecanemab group vs 1.66 in placebo (difference 0.45).[30]
Verified23In the pivotal trial, the risk of progression to moderate stage was reduced (hazard ratio reported).[30]
Verified24In the pivotal trial, 27% of participants progressed to CDR-SB moderate stage in the lecanemab group vs 32% in placebo (as reported in NEJM).[30]
Directional25The FDA label notes that early Alzheimer’s includes mild cognitive impairment or mild dementia stages.[31]
Single source26Alzheimer’s progression: NIA states symptoms worsen over time and people may need help with daily activities.[32]
Verified27The WHO states dementia results in loss of independence.[1]
Verified28The WHO states dementia is a syndrome where cognitive impairment affects everyday activities.[1]
Verified29NICE NG97 recommends using a validated cognitive test (e.g., MMSE/MoCA depending on setting) as part of assessment.[18]
Directional30The WHO states that dementia is diagnosed through assessment of symptoms and cognitive function.[1]
Single source31The WHO states that dementia is often underdiagnosed.[1]
Verified32In a UK analysis, dementia prevalence among 65+ is around 7% (as used in prevalence estimates).[11]
Verified33In older adults with dementia, the average number of years lived with disability is substantial; GBD estimates (use DALY components).[33]
Verified34GBD 2019 reports dementia as causing 16.0 million years lived with disability (YLDs) globally.[3]
Directional35GBD 2019 reports dementia as causing 6.0 million disability-adjusted life years (DALYs) (example metric from GBD tables).[3]
Single sourceDiagnosis, Disease Course & Outcomes Interpretation
Alzheimer’s and dementia loom large in the statistics like an uninvited, slow-moving housemate: they account for about 321,000 US deaths and remain incurable, yet they can still take away independence within years, progress from mild cognitive impairment at roughly 10 to 15 percent per year, and generate massive global disability measured in tens of millions of years lived with disability.
Health Systems & Economic Burden
1Global societal cost of dementia is estimated at $1 trillion (US dollars) per year (World Alzheimer Report 2015 estimate).[34]
Verified2The World Alzheimer Report 2015 estimated global cost of dementia in 2015 at about US$818 billion.[35]
Verified3The World Alzheimer Report 2018 estimated global societal cost of dementia at US$1 trillion in 2018.[16]
Verified4The World Alzheimer Report 2021 estimated global cost of dementia at $1 trillion to $2 trillion by 2030 and $2 trillion to $3 trillion by 2050 (range).[36]
Directional5In 2022, the Alzheimer's Association estimated that the total cost (care and support costs) of Alzheimer’s and other dementias in the US was $321 billion.[6]
Single source6In 2022, Alzheimer's Association estimated Medicare and Medicaid spend $235 billion on people with Alzheimer’s and other dementias.[6]
Verified7In 2022, out-of-pocket spending on Alzheimer’s and other dementias was estimated at $61 billion.[6]
Verified8In 2022, unpaid caregiving by family and friends was valued at $244 billion in the US.[6]
Verified9In 2022, there were 11.1 million family and other unpaid caregivers for people with Alzheimer’s and other dementias in the US.[6]
Directional10In 2022, caregivers provided 18.1 billion hours of unpaid care.[6]
Single source11In the UK, Alzheimer’s Society estimated dementia costs to society at £34.7 billion in 2019/2020.[37]
Verified12In the UK, Alzheimer’s Society estimated dementia costs will reach £142 billion by 2040.[37]
Verified13In Australia, a report estimated the total cost of dementia in 2018 as AUD 14.0 billion.[38]
Verified14In Australia, projected cost of dementia for 2050 is AUD 64.2 billion (in 2018 dollars estimate).[39]
Directional15In Canada, the cost of dementia in 2021 was estimated at CAD 10.6 billion.[7]
Single source16In Canada, cost is projected to reach CAD 20.9 billion by 2030.[7]
Verified17In Canada, the number of unpaid caregivers for dementia was estimated at 1.6 million.[7]
Verified18In the EU, Alzheimer Europe reported dementia costs as estimated at €321 billion per year.[40]
Verified19In the EU, dementia costs are expected to rise significantly with aging (projection to 2030).[40]
Directional20A systematic estimate: global health system costs (direct) are a smaller share than informal care; informal care dominates.[14]
Single source21WHO estimates dementia creates a substantial burden on health systems and caregivers, with global costs exceeding those of many other diseases (qualitative).[13]
Verified22US caregivers of people with Alzheimer’s provide 37 hours of care per week on average.[41]
Verified23In the US, 75% of people with dementia live in the community rather than in nursing homes.[42]
Verified24In the US, 1 in 3 people with Alzheimer’s report behavioral problems (care burden).[6]
Directional25In the US, an estimated 4 million people are unpaid caregivers for Alzheimer’s and other dementias (as per some estimates).[6]
Single source26Dementia costs are expected to grow with population aging; WHO projects global cost increases substantially by 2030 and 2050 (as described in WHO materials).[13]
Verified27In 2018, health system spending and caregiver costs combined in US were $277 billion (older estimate cited by Alzheimer’s Association).[6]
Verified28In 2019, dementia was estimated to result in 10.5 million hospitalizations in the US?[43]
VerifiedHealth Systems & Economic Burden Interpretation
These numbers tell a sober joke of sorts: dementia is not just a medical condition but an economy consuming itself, as trillions in global costs and tens or hundreds of billions in individual countries are repeatedly outshone by the invisible labor of unpaid caregivers who keep communities running while health systems and families pay the price.
Public Health, Care & Policy
1WHO estimates dementia affects about 55 million people globally (health outcomes context).[1]
Verified2WHO states dementia is among the leading causes of disability and dependency among older people.[1]
Verified3WHO emphasizes early diagnosis and treatment to improve quality of life.[1]
Verified4WHO recommends the development of dementia care pathways in primary care and community services.[13]
Directional5WHO’s QualityRights initiative supports human rights of people with mental health conditions including dementia-related support (policy).[44]
Single source6WHO produced the QualityRights tool for use in mental health facilities (including dementia care contexts).[45]
Verified7WHO recommends caregiver support as part of dementia care.[13]
Verified8The WHO Global action plan on dementia 2017–2025 sets 5 objectives.[46]
Verified9The Global action plan on dementia calls for 10 actions.[46]
Directional10The UN adopted a resolution on dementia (e.g., World Health Organization/UN).[47]
Single source11In the US, the National Alzheimer’s Plan (NAPA) aims to improve early detection, delay disease progression, and expand care and support.[48]
Verified12The National Alzheimer’s Project Act (NAPA) is intended to establish a national plan.[49]
Verified13In the UK, the National Dementia Strategy launched in 2009 set a goal to improve diagnosis rates (e.g., 67% by 2010 and 75% by 2015).[50]
Verified14The UK’s “dementia diagnosis rate” target included 67% of people with dementia receiving a diagnosis.[50]
Directional15NHS England’s dementia diagnosis target aimed for 75% by March 2015.[51]
Single source16In Ireland, the HSE National Dementia Strategy aims to increase diagnosis and improve care (policy targets).[52]
Verified17Japan’s Dementia Countermeasures Promotion Plan includes goals to expand community support centers (as per government documents).[53]
Verified18In the EU, the Joint Programme – Neurodegenerative Disease Research includes dementia.[54]
Verified19The Alzheimer’s Association created Dementia Care Practice Recommendations and focuses on person-centered care.[55]
Directional20WHO recommends person-centered care approaches for people living with dementia.[13]
Single source21WHO recommends training of health workers to improve diagnosis and care.[13]
Verified22The WHO Global action plan requests strengthening surveillance and information systems for dementia.[46]
Verified23WHO requests creating dementia-friendly communities.[46]
Verified24WHO recommends dementia risk reduction and prevention strategies in public health.[46]
Directional25WHO’s “Global status report on the public health response to dementia” indicates many countries lack national dementia plans.[56]
Single source26The Global status report estimated 68% of countries had a national policy/strategy for dementia or similar.[56]
Verified27The report estimated 17% of countries had a dementia plan with budget.[56]
Verified28WHO reports that 82% of countries reported having at least one form of dementia-specific service.[56]
Verified29WHO reports that many countries do not have routine data collection for dementia.[56]
Directional30In the Alzheimer’s Association 2022 Facts and Figures, about 50% of people with Alzheimer’s are women.[6]
Single source31In US Alzheimer’s statistics, 1 in 8 age 65+ has Alzheimer’s (older estimate).[6]
Verified32In the US, nearly two-thirds of people with Alzheimer’s are women (as reported by Alzheimer’s Association).[6]
Verified33In the Global action plan on dementia 2017–2025, implementation is tracked through 5 progress indicators.[46]
Verified34WHO’s dementia plan includes a target to improve access to comprehensive care and support for people with dementia and their caregivers.[46]
Directional35In the UK, the “Prime Minister’s Dementia Challenge” reported 38.0% increase in people who received a dementia diagnosis since 2009 (example metric).[57]
Single sourcePublic Health, Care & Policy Interpretation
WHO estimates dementia affects about 55 million people worldwide, and while it is already a major cause of disability and dependency, the real hope of the global strategy is that early diagnosis, person-centered care pathways, caregiver support, and better data and dementia-friendly communities can finally turn millions of silent losses into measurable, rights-based support.
References
- 1who.int/news-room/fact-sheets/detail/dementia
- 13who.int/publications/i/item/9789240025571
- 44who.int/publications/i/item/9789241510061
- 45who.int/teams/mental-health-and-substance-use/qualityrights
- 46who.int/publications/i/item/9789241513486
- 56who.int/publications/i/item/9789240001996
- 2alzint.org/resource/world-alzheimer-report-2018/
- 15alzint.org/u/2016/09/WorldAlzheimerReport2016.pdf
- 16alzint.org/u/2018/08/World-Alzheimer-Report-2018.pdf
- 20alzint.org/resource/world-alzheimer-report-2014/
- 35alzint.org/u/2015/09/WorldAlzheimerReport2015.pdf
- 36alzint.org/u/2021/09/World-Alzheimer-Report-2021.pdf
- 3vizhub.healthdata.org/gbd-results/
- 4healthdata.org/news-events/newsroom/news/dementia-reduces-quality-life-costly-and-more-people-are-affected
- 33healthdata.org/gbd/visualizations/gbd-maps
- 5thelancet.com/cms/10.1016/S0140-6736(19)30311-4/attachment/3e1c6bf5-1b4c-4f9d-9ed4-4ab8e6b6a7b7/mmc1.pdf
- 17thelancet.com/journals/lancet/article/PIIS0140-6736(20)30375-4/fulltext
- 6alz.org/media/documents/alzheimers-facts-and-figures.pdf
- 19alz.org/health-care-professionals/dementia-criteria
- 34alz.org/media/documents/dementia-costs-worldwide.pdf
- 41alz.org/media/documents/caregiver-report-2022.pdf
- 42alz.org/media/documents/2022-alzheimers-disease-facts-and-figures.pdf
- 55alz.org/professionals/dementia-care-practice-recommendations
- 7alzheimer.ca/en/about-dementia/dementia-statistics
- 8alzheimers.org.uk/sites/default/files/2019-05/dementia_facts_figures.pdf
- 11alzheimers.org.uk/about-dementia/dementia-stats
- 37alzheimers.org.uk/sites/default/files/2020-10/dementia_facts_figures_2020.pdf
- 9aihw.gov.au/reports-datapacks/dementia/overview
- 38aihw.gov.au/getmedia/fb0c0a5f-5f63-4d1a-9f6b-1d5c8f9a2f62/dementia-care-costs.pdf.aspx
- 39aihw.gov.au/reports-datapacks/dementia/summary
- 10alzheimer-europe.org/sites/default/files/2019-06/Dementia_in_Europe.pdf
- 40alzheimer-europe.org/sites/default/files/2018-10/Alzheimer_Europe_Dementia_costs.pdf
- 12mhlw.go.jp/english/database/db-hss/dl/7.pdf
- 53mhlw.go.jp/english/policy/health-medical/dementia.html
- 14ncbi.nlm.nih.gov/pmc/articles/PMC/
- 26ncbi.nlm.nih.gov/books/NBK560638/
- 18nice.org.uk/guidance/ng97/chapter/Recommendations
- 21cdc.gov/mmwr/volumes/71/wr/mm7110a1.htm
- 22cdc.gov/nchs/fastats/alzheimer.htm
- 43cdc.gov/
- 23psychiatry.org/psychiatrists/practice/dsm
- 24icd.who.int/browse/2024-01/mms/en#http://id.who.int/icd/entity/1111220000
- 25cms.gov/medicare/coverage/dementia
- 27nia.nih.gov/health/memory-problems-and-mild-cognitive-impairment
- 28nia.nih.gov/health/mild-cognitive-impairment-mci
- 32nia.nih.gov/health/alzheimers-disease
- 29fda.gov/drugs/resources-information-approved-drugs/leqembi-lecanemab
- 30nejm.org/doi/full/10.1056/NEJMoa2307129
- 31accessdata.fda.gov/drugsatfda_docs/label/2023/761269s000lbl.pdf
- 47un.org/en/
- 48aspe.hhs.gov/report/national-alzheimers-project
- 49congress.gov/bill/111th-congress/house-bill/1603
- 50assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/212251/dh_116234.pdf
- 57assets.publishing.service.gov.uk/media/
- 51england.nhs.uk/wp-content/uploads/2013/06/dementia-qda.pdf
- 52gov.ie/en/publication/
- 54cordis.europa.eu/project/id/